Revised 8-26-94 
Food and Drug Administration, and the manufacturer of the AdcvCFTR.10 vector 
(GenVec, Inc). 
Permission for Autopsy 
As described above, we do not believe that the therapy with AdsvCFTR.lO or the 
tests you will undergo will lead to adverse effects that will cause your 
death. However, as a participant in an innovative study involving the transfer 
of the normal CFTR gene to the cells lining your airways, it is important that 
you understand that should your death occur while in this study, it is of 
vital importance to potential future patients that your doctors are able to 
determine the precise cause of death. In this context, should you die while 
participating in this study, your doctors will ask your family to give permis- 
sion for a full autopsy. By signing this consent form, you cannot force your 
family to agree to this, but by doing so you are indicating your agreement 
that an autopsy be carried out. You should inform your family of your wishes 
regarding permission for autopsy. 
[240] 
Recombinant DNA Research, Volume 20 
